• Home
• Research
• Our guidance
• Training
• News
• Publications
• Databases
• PROSPERO
• About us
• Staff
• Intranet

NICE reaches 1000th appraisal

Posted on 23 September 2024

In September, the National Institute of Health and Care Excellence (NICE) reached a significant milestone by publishing its 1,000th Technology Appraisal, TA1000: Iptacopan for treating paroxysmal nocturnal haemoglobinuria.

The critical evaluation was conducted by the Centre for Reviews and Dissemnation (CRD) and the Centre for Health Economics (CHE) Technology Assessment Group, leading to a positive recommendation for the first oral treatment for this rare blood disorder. CRD colleagues contributing to the appraisal were Mark Rodgers, Chinyereugo Umemneku-Chikere, Helen Fulbright, Alison Eastwood and Sofia Dias. 

NICE guidance on Iptacopan

See our Technology Assessment Review programme of work to read about our evaluations for NICE over the last 25 years.